Loss-of-function mutations in NF1 lead to sustained RAS activation, triggering dysregulated downstream signaling primarily through the MAPK/ERK pathway, which drives abnormal cell proliferation and tumorigenesis, contributing to the development of NF1-associated neoplasms [2]. This evidence concerns the gene NF1 and neoplasm.